Regent Pacific Group Limited (RPGLF)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Jun 9, 2025

Regent Pacific Group Company Description

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.

The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels.

The company also invests in listed and unlisted corporate entities. In addition, it provides management services.

The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023.

Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.

Regent Pacific Group Limited
CountryCayman Islands
Founded1991
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees17
CEOJamie Alexander Gibson

Contact Details

Address:
Henley Building
Central
Hong Kong
Phone852 2514 6111
Websiteregentpac.com

Stock Details

Ticker SymbolRPGLF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberKYG3042R1231
SIC Code6799

Key Executives

NamePosition
Jamie Alexander GibsonChief Executive Officer and Executive Director
Dr. Michael Grant Wyllie BSc, D.Sc., DScCo-Founder and Chief Scientific Officer
Yui Fui WongChief Financial Officer
Paul Eric Jones BA, MBAInvestment Director
Mei Yan LuiCompany Secretary
Prof. John Michael Fitzpatrick FC Urol (SA), FRCS, FRCSGlas, FRCSI, MChChairman of Clinical Scientific Advisory Board